Sweetch
- Company typePrivate
- Founded2013
- HeadquartersTel Aviv-yafo, Israel
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Sweetch firmographics
Firmographics- Name
- Sweetch
- Legal name
- Sweetch Health Ltd.
- Website
- https://sweetch.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Sweetch industry classification
Industry- Product category
- Digital Therapeutics
- NAICS
- Computer Systems Design and Related Services (54151), Computer Systems Design Services (541512)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
- akta.pro secondary industries
- Therapeutic Companion Apps (Drug-Device-Digital Combination) (HLACANAH), Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ), DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)
Keywords
Where Sweetch is headquartered
LocationHeadquarters
- HQ city
- Tel Aviv-yafo
- HQ country
- Israel
- HQ region
- Middle East
Offices1 record
Markets served
Sweetch business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- B2B Platform Licensing/Subscription: Sweetch provides its platform to enterprise customers (pharma, med devices, payers, providers, pharmacies) who distribute it to their patients. Revenue likely comes from platform licensing fees, potentially tiered based on user volume or features.
- Virtual Patient Support Programs (PSP): Provides virtual patient support programs for pharmaceutical and medical device companies to improve treatment adherence, retention and engagement of their customers.
- RPM (Remote Patient Monitoring): Continuous remote patient monitoring with reimbursable data sync and analysis for healthcare providers, generating revenue through healthcare reimbursement mechanisms.
Go-to-market motion2 records
Distribution channels6 records
Marketing channels6 records
Sweetch product offering
Product offeringCore offering
Sweetch provides a clinically validated Just-in-Time Adaptive Intervention (JITAI) digital therapeutics platform that combines behavioral science with AI and emotional intelligence to deliver hyper-personalized health recommendations. The platform addresses medication adherence, physical activity, weight management, nutrition, sleep, mood, CGM engagement for Type 2 diabetes, remote patient monitoring, PROMS, education, and treatment follow-up. It is offered as a B2B enterprise solution, including white-label deployments, to pharmaceutical companies, medical device manufacturers, payers, healthcare providers, and pharmacies, who deliver it to their patients.
Product overview
Sweetch is a clinically validated Just-In-Time Adaptive AI (JITAI) platform that combines behavioral science with AI and emotional intelligence (EI) to deliver hyper-personalized health recommendations. The platform architecture consists of a core Sweetch Platform that serves as the foundation, with multiple intervention domain modules including Medication Adherence, Physical Activity, Weight Management, Nutrition & Meals, Sleep, and Mood. Additional modules provide Remote Patient Monitoring (RPM), PROMS collection, Education & Content, Gamification, Community Support, and Treatment Follow-Up capabilities. The platform includes specialized solutions for CGM engagement (for Type 2 diabetes), a Digital Health Coach for Diabetes Prevention Programs, Virtual Patient Support Programs (PSP), and a White Label App option. Sweetch addresses multiple chronic conditions including Diabetes, Obesity, Cardiovascular diseases (hypertension, high cholesterol, coronary artery disease, congestive heart failure), Autoimmune conditions, and Oncology, with support for comorbidities and multiple health domains. The platform is offered to healthcare organizations including Pharma, Medical Device manufacturers, Payers, Healthcare Providers, and Pharmacies.
Differentiator
Problem solved
Functional benefit
Products and services
- Sweetch Platform A clinically validated Just-in-Time Adaptive AI (JITAI) platform that combines behavioral science with AI and emotional intelligence to drive long-lasting behavior change and improved health outcomes for individuals with chronic conditions at scale; offered to enterprise healthcare organizations as a white-label or embedded solution.
- CGM Engagement Platform for Type 2 Diabetes AI-powered continuous glucose monitoring engagement platform for Type 2 diabetes that connects with blood glucose monitors and analyzes how meals, activity, and behavior affect blood sugar; designed for use by pharma, device manufacturers, and providers serving T2D patients.
- White Label App White-label version of the Sweetch platform that allows enterprise partners (pharma, payers, providers, device makers) to deploy the technology under their own brand for patient engagement programs.
- Virtual Patient Support Programs (PSP) Virtual patient support program enhancement enabling pharmaceutical companies and medical device companies to deliver automated, hyper-personalized patient support and improve adherence, retention, and engagement.
- Remote Patient Monitoring (RPM) Connected devices and remote patient monitoring capabilities enabling continuous and reimbursable remote patient monitoring with automated data sync and analysis for healthcare providers.
- Management Dashboard Data and insights management dashboard providing actionable insights about patients and populations for healthcare providers, pharmaceutical companies, and payers.
Quantifiable outcome
- 86% patient retention in clinical trial at Johns Hopkins
- +3 more outcomes
Companies that use Sweetch
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
Sweetch technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature4 records
Sweetch partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered flagship and core.
- Grupo Fleury's Saúde iDflagshipStrategic partnership to tackle Brazil's chronic disease prevalence, particularly amid the COVID-19 pandemic. Grupo Fleury distributes Sweetch to Brazilian patients through its digital health platform, providing regional market access for Sweetch in Latin America.
- Bayer G4AflagshipSelected as one of Bayer's Agents of Change for 2020 in their Digital Health Partnerships Program. Bayer G4A provides marketing and partnership support to help digital health innovators scale their solutions, with Sweetch participating to expand its reach in the pharmaceutical digital health ecosystem.
- Johns HopkinscoreClinical validation partner that conducted a clinical trial demonstrating Sweetch's effectiveness. The trial achieved clinically significant HbA1C reduction, weight loss, and physical activity increase with 86% patient retention. Published in JMIR (Journal of Medical Internet Research).
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Sweetch competitors and assessment
Company assessmentDirect peers
- Omada Health: US-based digital chronic disease prevention and management platform covering diabetes, hypertension, and behavioral health. Closely comparable to Sweetch as both sell B2B to payers, employers, and providers, deploy AI-driven personalized coaching, and target medication adherence plus lifestyle outcomes.
- Livongo (Teladoc Health): Now part of Teladoc Health, Livongo pioneered AI-powered chronic condition management (diabetes, hypertension, weight, mental health) sold to employers, payers, and providers. Direct functional peer to Sweetch's chronic-condition DTx offering and white-label model.
- Virta Health: Digital health company focused on type 2 diabetes reversal and metabolic health via clinician-supervised, AI-personalized nutrition and behavior change. Comparable to Sweetch's CGM-for-T2D and weight management modules and similar enterprise/payer GTM.
- WellDoc: Developer of FDA-cleared digital therapeutics for diabetes (BlueStar) and other chronic conditions, sold to health plans, providers, and employers. Closely aligned with Sweetch on regulated DTx for diabetes, B2B distribution, and pharma partnerships.
- DarioHealth: Global digital therapeutics company offering AI-driven, data-collected chronic condition management (diabetes, hypertension, musculoskeletal, behavioral) sold to payers, employers, and pharma. Direct peer across conditions, channels, and target buyers.
- Vida Health: Virtual chronic care platform combining AI coaching with human clinicians for diabetes, weight, mental health, and hypertension. Comparable to Sweetch in B2B payer/employer sales, condition coverage, and personalized engagement model.
- Noom: Behavior change platform with strong presence in weight management, diabetes prevention, and chronic condition coaching. Comparable to Sweetch on AI-personalized coaching, employer/payer/B2B sales motion, and mobile-first delivery.
- Sidekick Health: European-originated digital therapeutics company delivering gamified, AI-personalized care for chronic and autoimmune conditions via pharma and payer partnerships. Comparable to Sweetch on DTx modular platform, pharma commercialization, and chronic-condition focus.
- mySugr (Roche): Acquired by Roche, mySugr is a leading diabetes management app with CGM/BGM integration and behavior change features. Direct overlap with Sweetch's CGM-for-T2D module and a notable signal of pharma appetite to acquire in this category.
- Aptar Digital Health (Voluntis): Aptar Pharma's digital health arm (formerly Voluntis) develops FDA-cleared digital therapeutics for chronic conditions, sold to pharma and medtech for companion apps. Comparable to Sweetch on therapeutic companion apps, pharma partnership model, and SaMD regulatory pathway.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Sweetch social profiles
Digital presenceSweetch compliance and trust
Trust signalCompliance4 records
Sweetch financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sweetch leadership team
Management profileNumber of profiles
Profiles10 records
Sweetch funding detail
Funding detailFunding overview
Funding rounds7 records
Investors17 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sweetch M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sweetch
What does Sweetch do?
Sweetch provides a clinically validated Just-in-Time Adaptive Intervention (JITAI) digital therapeutics platform that combines behavioral science with AI and emotional intelligence to deliver hyper-personalized health recommendations. The platform addresses medication adherence, physical activity, weight management, nutrition, sleep, mood, CGM engagement for Type 2 diabetes, remote patient monitoring, PROMS, education, and treatment follow-up. It is offered as a B2B enterprise solution, including white-label deployments, to pharmaceutical companies, medical device manufacturers, payers, healthcare providers, and pharmacies, who deliver it to their patients.
Is Sweetch a public or private company?
Sweetch is a private company. It is classified as venture growth investor backed and is currently operating.
When was Sweetch founded?
Sweetch was founded in 2013. It employs 11 to 50 people.
Where is Sweetch based?
Sweetch is headquartered in Tel Aviv-yafo, Israel, in the Middle East region.
How does Sweetch make money?
Three revenue lines are on record. B2B Platform Licensing/Subscription is the primary driver. The others are virtual Patient Support Programs (PSP) and RPM (Remote Patient Monitoring).
Who are Sweetch's main competitors?
Direct peers on record are Omada Health, Livongo (Teladoc Health), Virta Health, WellDoc, DarioHealth, Vida Health, Noom, Sidekick Health, mySugr (Roche) and Aptar Digital Health (Voluntis).
Does Sweetch have an API?
No public API is recorded for Sweetch.
What industry is Sweetch in?
Sweetch's product category is Digital Therapeutics. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLACANAH, Therapeutic Companion Apps (Drug-Device-Digital Combination). Its NAICS code is 54151 and its SIC code is 7372.